<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Acknowledgements</title>
 <p>The authors would like to thank the staff of the participating institutions for their support in recruiting eligible patients, and the patients who participated in this study. We thank Melissa Crawford, PhD, from Edanz Group (
  <ext-link ext-link-type="uri" xlink:href="https://en-author-services.edanzgroup.com/" xmlns:xlink="http://www.w3.org/1999/xlink">https://en-author-services.edanzgroup.com/</ext-link>) for editing a draft of this manuscript.
 </p>
 <sec id="FPar1">
  <title>Current study status</title>
  <p id="Par45">The trial began recruiting patients in July 2017 and will complete recruitment in March 2022. Data collection will be completed in July 2022, and the results are scheduled to be published in November 2022.</p>
 </sec>
</ack>
